This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Voigt, A. Articles by Saba, S. Search for Related Content PubMed PubMed Citation Articles by Voigt, A. Articles by Saba, S.

Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001

Andrew Voigt, MD^*, Rana Ezzeddine, PhD, William Barrington, MD^*, Ogundu Obiaha-Ngwu, MD^*, Leonard I. Ganz, MD^*, Barry London, MD, PhD^* and Samir Saba, MD^*,*

^* Cardiovascular Institute
Department of Biostatistics, University of Pittsburgh, Pittsburgh, PennsylvaniaUSA

View larger version (17K): [in a new window]   Figure 1 Percentage of patients admitted to the hospital with a primary diagnosis of ventricular flutter, ventricular fibrillation, or cardiac arrest and surviving to discharge, who received an implantable cardioverter-defibrillator (ICD) stratified by race. Note the significantly lower utilization rate in black patients (broken line) compared with white patients (solid line). In 2001, even though closing, the racial gap does not seem to have disappeared.

View larger version (18K): [in a new window]   Figure 2 Percentage of patients admitted to the hospital with a primary diagnosis of ventricular flutter, ventricular fibrillation, or cardiac arrest and surviving to discharge, who received an implantable cardioverter-defibrillator (ICD) stratified by gender. Note the lower rates of utilization of the defibrillator in women (broken line) compared to men (solid line) in the early years. In 2001, the ratio of men to women receiving a defibrillator seems to have reversed, with more women receiving an ICD.